Home > Clinical Resources > Guidance >
First published on 01 Jun 2014
Author Mark Wilkinson, (BSG Endoscopy, working party convenor and chairman) et al. June 2014 Executive Summary To improve the quality and availability of ERCP in the UK, a working party was set up incorporating a number of stakeholders (Appendix 3) to […]
First published on 01 Oct 2013
Faecal calprotectin testing is recommended as an option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) in adults with recent onset lower gastrointestinal symptoms for whom specialist assessment is being considered, […]
First published on 04 Nov 2011
The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with […]